Faculty Information - Yoshihiro Kobashi

（Last updated : 2022-05-24 16:21:25）

Yoshihiro Kobashi
Department Kawasaki Medical School Kawasaki Medical School, Department of Respiratory Medicine,

Position Associate Professor

■ Journal

1.	2018/04	Clinical analysis of pulmonary nocardiosis in a tertiary hospital.
2.	2018/04	A case of necrotizing pneumonia caused by co-infection with influenza B and a Paton-Valentine leukocidin negative community acquired methicillin-resistant Staphylococcus aureus strain.
3.	2017/04	Clinical analysis of military tuberculosis patients in our tertiary hospital.
4.	2015/06	Clinical evaluation of IP-10 and MIG for the diagnosis of active tuberculosis disease
5.	2016/11	Pulmonary Mycobacterium kansasii disease in previously healthy women
6.	2016/11	Clinical analysis of pulmonary nontuberculous Mycobacterial disease complicated by lung cancer during the follow-up periods
7.	2015/12	Clinical evaluation of new biomarkers including IFN-gamma for the diagnosis of active tuberculosis disease
8.	2013/07	Combined chemotherapy for nontuberculous mycobacterial NTM disease
9.	2013/08	Clinical application of T-SPOT
10.	2014/01	Serological diagnosis of Mycobacterium avium complex disease
11.	2022/02/15	Nocardisosis in Japan: a multicentric retrospective study
12.	2021/04/22	Pulmonary cryptococcosis complicated by pneumococcal pneumonia co-infection with influenza A virus
13.	2020/10/31	Nontuberculous mycobacteria
14.	2020/06/18	Clinical characteristics of tuberculosis patients in a tertiary hospital.
15.	2019/11/14	Pulmonary Mycobacterium avium complex disease requiring differentiation from recurrence of lung cancer during the follow-up period for lung cancer
16.	2019/04	Pulmonary Mycobacterium kansasii disease with solitary nodule.
17.	2011/05	Pulmonary Mycobacterium massiliense disease with septicemia during immunosuppressive treatment.
18.	2011/04	Solitary pulmonary nodule due to Mycobacterium kansasii.
19.	2010/09	Rapid diagnosis of tuberculous pericarditis by ELISPOT assay.
20.	2010	Comparison of T-cell interferon-gamma release assays for Mycobacterium tuberculosis-specific antigens in patients with active and latent tuberculosis.
21.	2009/11	Clinical evaluation of the QuantiFERON-TB Gold test in patients with non-tuberculous mycobacterial disease.
22.	2009/11	Clinical usefulness of fluoro-2-deoxy-D-glucose PET in a case with multiple bone metastases of carcinoid tumor after ten years.
23.	2009/10	Clinical evaluation of QuantiFERON TB-2G test in patients with healed pulmonary tuberculosis.
24.	2009/07	False negative results of QuantiFERON TB-2G test in patients with active tuberculosis.
25.	2009/05	Clinical usefulness of QuantiFERON TB-2G test for the early diagnosis of pulmonary Mycobacterium kansasii disease.
26.	2009/04	Indeterminate results of QuantiFERON TB-2G test performed in routine clinical practice.
27.	2009/03	Clinical utility of a T cell-based assay in the diagnosis of extrapulmonary tuberculosis.
28.	2009/03	Rapid diagnosis of tuberculous pleuritis by a T-cell interferon-gamma release assay.
29.	2009/03	Transitional changes in T-cell responses to Mycobacterium tuberculosis-specific antigens during treatment.
30.	2009/02	Clinical evaluation of the T-SPOT.TB test for patients with indeterminate results on the QuantiFERON TB-2G test.
31.	2008/11	Clinical analysis of cases of empyema due to Streptococcus milleri group.
32.	2008/11	Long-term follow-up of the QuantiFERON TB-2G test for active tuberculosis disease.
33.	2008/08	Clinicopathological analysis of multifocal micronodular pneumocyte hyperplasia associated with tuberous sclerosis in Japan.
34.	2008/06	Multifocal micronodular pneumocyte hyperplasia associated with tuberous sclerosis: differentiation from multiple atypical adenomatous hyperplasia.
35.	2008/05	Clinical utility of the QuantiFERON TB-2G test for elderly patients with active tuberculosis.
36.	2008/04	Clinical evaluation for diagnosis active TB disease and transitional change of two commercial blood tests.
37.	2008/03	Transitional change in the clinical features of pulmonary tuberculosis.
38.	2008/02	Usefulness of the QuantiFERON TB-2G test for the differential diagnosis of pulmonary tuberculosis.
39.	2007/12	An indeterminate QuantiFERON TB-2G response for miliary tuberculosis, due to severe pancytopenia.
40.	2007/12	Clinical features of immunocompromised and nonimmunocompromised patients with pulmonary tuberculosis.
41.	2007/12	Clinical features of severe Mycoplasma pneumoniae pneumonia in adults admitted to an intensive care unit.
42.	2007/11	Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients.
43.	2007/09	Pulmonary alveolar proteinosis with bilateral ground-glass opacities localized in subpleural areas.
44.	2007/09	The microbiological and clinical effects of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease in Japan-including a follow-up study.
45.	2007/09	Usefulness of QuantiFERON TB-2G, a diagnostic method for latent tuberculosis infection, in a contact investigation of health care workers.
46.	2007/05	Evaluating the use of a Streptococcus pneumoniae urinary antigen detection kit for the management of community-acquired pneumonia in Japan.
47.	2007/05	Paclitaxel and cisplatin with concurrent radiotherapy followed by surgery in locally advanced thymic carcinoma.
48.	2006/12	Inflammatory pseudotumor of the lung: clinicopathological analysis in seven adult patients.
49.	2006/10	Sibling cases of Mycobacterium avium complex disease associated with hematological disease.
50.	2006	Both bronchial and vascular stenting followed by chemoradiotherapy for locally advanced non-small cell lung cancer.
51.	2006	Chronic necrotizing pulmonary aspergillosis as a complicationof pulmonary Mycobacterium avium complex disease.
52.	2006	Clinical reevaluation of the QuantiFERON TB-2G test as a diagnostic method for differentiating active tuberculosis from nontuberculous mycobacteriosis.
53.	2006	Four cases of pulmonary Mycobacterium avium intracellulare complex presenting as a solitary pulmonary nodule and a review of other cases in Japan.
54.	2006	Pulmonary Mycobacterium intracrellurare disease with a solitary pulmonary nodule detected at the onset of pneumothorax.
55.	2006	Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates.
56.	2006	Synchronous presentation of early-stage small cell carcinoma and adenocarcinoma in the same lung lobe.
57.	2005	Chronic necrotizing pulmonary aspergillosis complicated by a cavitary lesion caused by pulmonary Mycobacterium-avium complex disease.
58.	2005	Community-acquired pneumonia in Japan: a prospective ambulatory and hospitalized patient study.
59.	2005	Hermansky-Pudlak syndrome with interstitial pneumonia without mutation of HSP1 gene.
60.	2005	Infectious bulla of the lung caused by Mycobacterium intracellulare.
61.	2005	Lung adenocarcinoma required the differentiation for Wegener granulomatosis.
62.	2005	Multifocal micronodular pneumocyte hyperplasia in a man with tuberous sclerosis.
63.	2005	Self-limiting pneumonia due to Chlamydia pneumoniae.
64.	2004	Pulmonary mycobacterium avium disease with a solitary pulmonary nodule requiring differentiation from recurrence of pulmonary adenocarcinoma.
65.	2004	Thoracic actinomycosis with mainly pleural involvement
Display 5 items
Display all(65)

■ Presentation

1.	2007/12	Clinical features of severe Mycoplasma pneumoniae in adults admitted to an intensive care unit （Poster notice，General）
2.	2004/09	Is it possible to distinguish between Chlamydia pneumoniae pneumonia and bacterial pneumonia? （Speech，General）
3.	2004/02	Chlamydia pneumoniae infection in adult patients with persistent cough. （Speech，General）